Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
Cytotoxic T-lymphocyte antigen 4 (CTLA4) is a co-receptor expressed by activated, memory T cells and regulatory T cells 1,2,3,4,5,6. It is a homodimer that can bind to the homodimeric ligands CD80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback